Role of lymphotoxin in experimental models of infectious diseases: potential benefits and risks of a therapeutic inhibition of the lymphotoxin-beta receptor pathway

Infect Immun. 2005 Nov;73(11):7077-88. doi: 10.1128/IAI.73.11.7077-7088.2005.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Autoimmune Diseases / drug therapy
  • Autoimmune Diseases / physiopathology
  • Communicable Diseases / physiopathology*
  • Gene Expression Regulation
  • Humans
  • Lymphotoxin beta Receptor
  • Lymphotoxin-alpha / antagonists & inhibitors
  • Lymphotoxin-alpha / physiology*
  • Lymphotoxin-beta
  • Membrane Proteins / antagonists & inhibitors
  • Membrane Proteins / physiology*
  • Receptors, Tumor Necrosis Factor / antagonists & inhibitors*
  • Receptors, Tumor Necrosis Factor / physiology
  • Signal Transduction / drug effects
  • Signal Transduction / physiology*

Substances

  • LTB protein, human
  • LTBR protein, human
  • Lymphotoxin beta Receptor
  • Lymphotoxin-alpha
  • Lymphotoxin-beta
  • Membrane Proteins
  • Receptors, Tumor Necrosis Factor